| VRTX | Vertex Pharmaceuticals Inc | $121.26B | +945496.26% |
| VRNA | Verona Pharma Plc | $77.75B | +606198.53% |
| REGN | Regeneron Pharmaceuticals Inc | $69.10B | +538785.16% |
| ARGX | Argen X SE | $57.12B | +445365.89% |
| ALNY | Alnylam Pharmaceuticals Inc | $36.95B | +288058.81% |
| RVMD | Revolution Medicines Inc | $36.92B | +287821.04% |
| ONC | BeiGene Ltd | $36.03B | +280912.04% |
| MRNA | Moderna Inc | $27.11B | +211290.08% |
| ROIV | Roivant Sciences Ltd | $25.13B | +195895.70% |
| RPRX | Royalty Pharma plc - Class A | $24.60B | +191704.50% |
| INSM | Insmed Inc | $23.78B | +185314.71% |
| BNTX | BioNTech SE | $23.26B | +181310.74% |
| INCY | Incyte Corp | $23.01B | +179355.22% |
| GMAB | Genmab | $18.57B | +144708.07% |
| ASND | Ascendis Pharma A/S | $17.33B | +135034.28% |
| BBIO | BridgeBio Pharma Inc | $16.18B | +126054.83% |
| JAZZ | Jazz Pharmaceuticals plc | $14.81B | +115423.47% |
| EXEL | Exelixis Inc | $14.09B | +109802.31% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.68B | +98773.35% |
| AXSM | Axsome Therapeutics Inc | $12.21B | +95147.78% |
| SMMT | Summit Therapeutics Inc | $11.69B | +91098.00% |
| BMRN | Biomarin Pharmaceutical Inc | $11.39B | +88747.72% |
| TECH | Bio-Techne Corp | $11.19B | +87145.72% |
| ABVX | Abivax | $10.86B | +84575.12% |
| KRYS | Krystal Biotech Inc | $10.31B | +80300.71% |
| CYTK | Cytokinetics Inc | $10.18B | +79324.36% |
| ARWR | Arrowhead Pharmaceuticals Inc | $10.10B | +78630.27% |
| APGE | Apogee Therapeutics Inc | $10.06B | +78319.49% |
| NUVL | Nuvalent Inc - Class A | $9.75B | +75948.97% |
| KYMR | Kymera Therapeutics Inc | $9.38B | +73037.41% |
| CORT | Corcept Therapeutics Inc | $9.35B | +72847.30% |
| IONS | Ionis Pharmaceuticals Inc | $9.08B | +70707.26% |
| HALO | Halozyme Therapeutics Inc | $8.99B | +69978.85% |
| PRAX | Praxis Precision Medicines Inc | $8.87B | +69079.03% |
| CRNX | Crinetics Pharmaceuticals Inc | $8.84B | +68804.67% |
| PTGX | Protagonist Therapeutics Inc | $8.70B | +67746.85% |
| TGTX | TG Therapeutics Inc | $8.64B | +67246.42% |
| PCVX | Vaxcyte Inc | $8.19B | +63755.94% |
| IMVT | Immunovant Inc | $8.13B | +63324.77% |
| IBRX | ImmunityBio Inc | $8.10B | +63034.72% |
| SYRE | Spyre Therapeutics Inc | $8.05B | +62654.45% |
| RYTM | Rhythm Pharmaceuticals Inc | $7.51B | +58447.71% |
| MTSR | Metsera Inc | $7.40B | +57643.73% |
| MIRM | Mirum Pharmaceuticals Inc | $7.37B | +57389.67% |
| MRUS | Merus N.V | $6.83B | +53128.82% |
| ACLX | Arcellx Inc | $6.67B | +51882.98% |
| XENE | Xenon Pharmaceuticals Inc | $6.54B | +50919.82% |
| PTCT | PTC Therapeutics Inc | $6.53B | +50857.43% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +50544.34% |
| SRRK | Scholar Rock Holding Corp | $6.44B | +50092.80% |
| CGON | Cg Oncology Inc | $6.42B | +50000.77% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | +48768.30% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +46281.17% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $5.93B | +46173.55% |
| BLTE | Belite Bio Inc | $5.88B | +45755.19% |
| ERAS | Erasca Inc | $5.51B | +42841.11% |
| DNTH | Dianthus Therapeutics Inc | $5.45B | +42427.02% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +40830.85% |
| TVTX | Travere Therapeutics Inc | $5.24B | +40786.46% |
| CRSP | CRISPR Therapeutics AG | $4.95B | +38511.96% |
| CAI | Caris Life Sciences Inc - Class A | $4.94B | +38385.30% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +35025.73% |
| ACAD | Acadia Pharmaceuticals Inc | $4.43B | +34482.04% |
| CELC | Celcuity Inc | $4.42B | +34401.83% |
| EWTX | Edgewise Therapeutics Inc | $4.39B | +34122.66% |
| VKTX | Viking Therapeutics Inc | $4.38B | +34071.81% |
| AKRO | Akero Therapeutics Inc | $4.38B | +34057.81% |
| TNGX | Tango Therapeutics Inc | $4.36B | +33907.79% |
| ORKA | ARCA biopharma Inc | $4.35B | +33799.45% |
| LEGN | Legend Biotech Corp | $4.26B | +33091.57% |
| DYN | Dyne Therapeutics Inc | $3.96B | +30806.11% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | +29903.92% |
| TLX | Telix Pharmaceuticals Ltd | $3.82B | +29727.01% |
| NAMS | NewAmsterdam Pharma Company NV | $3.73B | +28989.26% |
| RLAY | Relay Therapeutics Inc | $3.69B | +28687.28% |
| DNLI | Denali Therapeutics Inc | $3.65B | +28381.53% |
| ALMS | Alumis Inc | $3.60B | +27995.05% |
| GPCR | Structure Therapeutics Inc | $3.53B | +27400.44% |
| RCUS | Arcus Biosciences Inc | $3.52B | +27322.84% |
| ARQT | Arcutis Biotherapeutics Inc | $3.47B | +26988.74% |
| ELVN | Enliven Therapeutics Inc | $3.24B | +25142.31% |
| IDYA | Ideaya Biosciences Inc | $3.23B | +25071.66% |
| BEAM | Beam Therapeutics Inc | $3.17B | +24609.41% |
| RARE | Ultragenyx Pharmaceutical Inc | $3.12B | +24208.06% |
| VERA | Vera Therapeutics Inc - Class A | $3.04B | +23589.36% |
| IRON | Disc Medicine Inc | $2.90B | +22540.36% |
| MBX | MBX Biosciences Inc | $2.89B | +22408.56% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +21279.69% |
| KOD | Kodiak Sciences Inc | $2.64B | +20461.37% |
| IMNM | Immunome Inc | $2.59B | +20127.95% |
| QURE | uniQure N.V. | $2.58B | +20053.67% |
| CLDX | Celldex Therapeutics Inc | $2.55B | +19787.70% |
| TARS | Tarsus Pharmaceuticals Inc | $2.47B | +19190.88% |
| NRIX | Nurix Therapeutics Inc | $2.47B | +19187.42% |
| MLYS | Mineralys Therapeutics Inc | $2.43B | +18863.92% |
| VCEL | Vericel Corp | $2.38B | +18484.84% |
| AGIO | Agios Pharmaceuticals Inc | $2.37B | +18350.33% |
| MESO | Mesoblast Ltd | $2.36B | +18278.25% |
| ETNB | 89bio Inc | $2.34B | +18170.99% |
| TRVI | Trevi Therapeutics Inc | $2.33B | +18070.21% |
| SLS | SELLAS Life Sciences Group Inc | $2.32B | +17986.18% |
| PHVS | Pharvaris NV | $2.30B | +17805.96% |
| ZLAB | Zai Lab Ltd | $2.27B | +17596.83% |
| BHVN | Biohaven Ltd | $2.24B | +17352.87% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +17190.55% |
| OCUL | Ocular Therapeutix Inc | $2.18B | +16901.98% |
| PVLA | Palvella Therapeutics Inc | $2.18B | +16863.25% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.11B | +16318.67% |
| SNDX | Syndax Pharmaceuticals Inc | $2.08B | +16140.39% |
| IOVA | Iovance Biotherapeutics Inc | $2.08B | +16094.17% |
| ABCL | AbCellera Biologics Inc | $2.05B | +15875.57% |
| NUVB | Nuvation Bio Inc - Class A | $2.04B | +15842.65% |
| HRMY | Harmony Biosciences Holdings Inc | $2.02B | +15649.25% |
| ADMA | Adma Biologics Inc | $2.02B | +15623.49% |
| SION | Sionna Therapeutics Inc | $2.00B | +15500.19% |
| GLUE | Monte Rosa Therapeutics Inc | $1.97B | +15293.64% |
| ATAI | ATAI Life Sciences N.V. | $1.96B | +15180.15% |
| VRDN | Viridian Therapeutics Inc | $1.95B | +15128.94% |
| URGN | UroGen Pharma Ltd | $1.94B | +15017.73% |
| TYRA | Tyra Biosciences Inc | $1.93B | +14916.65% |
| NBTX | Nanobiotix | $1.91B | +14801.58% |
| RAPP | Rapport Therapeutics Inc | $1.91B | +14786.60% |
| GLPG | Galapagos NV | $1.90B | +14703.28% |
| AAPG | Ascentage Pharma Group International | $1.87B | +14472.93% |
| STOK | Stoke Therapeutics Inc | $1.86B | +14417.41% |
| SRPT | Sarepta Therapeutics Inc | $1.86B | +14397.90% |
| BCAX | Bicara Therapeutics Inc | $1.84B | +14271.16% |
| ZBIO | Zenas Biopharma Inc | $1.83B | +14207.52% |
| PGEN | Precigen Inc | $1.82B | +14110.30% |
| ZYME | Zymeworks BC Inc | $1.80B | +13958.11% |
| TSHA | Taysha Gene Therapies Inc | $1.78B | +13767.30% |
| IMCR | Immunocore Holdings plc | $1.76B | +13647.26% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.76B | +13596.80% |
| FTRE | Fortrea Holdings Inc | $1.69B | +13112.57% |
| NKTR | Nektar Therapeutics | $1.69B | +13075.04% |
| MPLT | MapLight Therapeutics Inc | $1.69B | +13060.81% |
| GHRS | GH Research PLC | $1.67B | +12922.84% |
| ANAB | AnaptysBio Inc | $1.62B | +12537.15% |
| INVA | Innoviva Inc | $1.62B | +12499.40% |
| NTLA | Intellia Therapeutics Inc | $1.57B | +12148.31% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +12099.67% |
| VIR | Vir Biotechnology Inc | $1.55B | +11983.17% |
| SEPN | Septerna Inc | $1.53B | +11833.82% |
| AVBP | ArriVent BioPharma Inc | $1.49B | +11542.33% |
| ABSI | Absci Corp | $1.49B | +11542.16% |
| MAZE | Maze Therapeutics Inc | $1.46B | +11299.48% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.42B | +10994.05% |
| NVAX | Novavax Inc | $1.39B | +10709.10% |
| KALV | KalVista Pharmaceuticals Inc | $1.38B | +10688.28% |
| INBX | Inhibrx Biosciences Inc | $1.33B | +10291.07% |
| ARDX | Ardelyx Inc | $1.31B | +10107.67% |
| IMTX | Immatics N.V | $1.28B | +9843.53% |
| MNKD | Mannkind Corp | $1.26B | +9752.63% |
| ANNX | Annexon Inc | $1.26B | +9743.81% |
| CRVS | Corvus Pharmaceuticals Inc | $1.25B | +9683.99% |
| TRML | Tourmaline Bio Inc | $1.24B | +9536.57% |
| SVRA | Savara Inc | $1.19B | +9184.65% |
| CAPR | Capricor Therapeutics Inc | $1.17B | +9051.13% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.16B | +8913.48% |
| ORIC | ORIC Pharmaceuticals Inc | $1.15B | +8890.19% |
| WVE | Wave Life Sciences Ltd | $1.14B | +8764.46% |
| XNCR | Xencor Inc | $1.11B | +8552.06% |
| DRTS | Alpha Tau Medical Ltd | $1.10B | +8451.64% |
| CGEM | Cullinan Oncology Inc | $1.10B | +8444.44% |
| JBIO | Jade Biosciences Inc | $1.08B | +8312.06% |
| CVAC | CureVac N.V. | $1.05B | +8082.81% |
| OLMA | Olema Pharmaceuticals Inc | $1.03B | +7950.01% |
| MGTX | MeiraGTx Holdings plc | $1.02B | +7877.39% |
| KURA | Kura Oncology Inc | $1.01B | +7742.64% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +7688.31% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +7619.29% |
| VOR | Vor Biopharma Inc | $979.68M | +7539.81% |
| JANX | Janux Therapeutics Inc | $975.67M | +7508.60% |
| ANRO | Alto Neuroscience Inc | $973.06M | +7488.25% |
| SANA | Sana Biotechnology Inc | $957.85M | +7369.62% |
| GERN | Geron Corp | $950.51M | +7312.39% |
| SLDB | Solid Biosciences Inc | $946.56M | +7281.55% |
| PHAR | Pharming Group N.V. | $939.88M | +7229.49% |
| LXRX | Lexicon Pharmaceuticals Inc | $936.56M | +7203.57% |
| DBVT | DBV Technologies | $930.17M | +7153.72% |
| LBRX | LB Pharmaceuticals Inc | $922.18M | +7091.47% |
| ABUS | Arbutus Biopharma Corp | $898.08M | +6903.52% |
| PHAT | Phathom Pharmaceuticals Inc | $877.84M | +6745.66% |
| TBPH | Theravance Biopharma Inc | $872.15M | +6701.29% |
| DSGN | Design Therapeutics Inc | $844.21M | +6483.40% |
| REPL | Replimune Group Inc | $800.70M | +6144.11% |
| ACRS | Aclaris Therapeutics Inc | $782.06M | +5998.72% |
| OCS | Oculis Holding AG | $772.84M | +5926.83% |
| ZVRA | Zevra Therapeutics Inc | $766.13M | +5874.51% |
| CMRX | Chimerix Inc | $766.03M | +5873.74% |
| RIGL | Rigel Pharmaceuticals | $758.21M | +5812.73% |
| SPRY | ARS Pharmaceuticals Inc | $749.72M | +5746.52% |
| OMER | Omeros Corporation | $746.63M | +5722.42% |
| MNPR | Monopar Therapeutics Inc | $728.12M | +5578.11% |
| DRUG | Bright Minds Biosciences Inc | $728.06M | +5577.64% |
| ATXS | Astria Therapeutics Inc | $709.95M | +5436.42% |
| CADL | Candel Therapeutics Inc | $706.21M | +5407.21% |
| XOMA | XOMA Royalty Corp | $699.64M | +5356.02% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $673.55M | +5152.54% |
| CLYM | Eliem Therapeutics Inc | $662.55M | +5066.77% |
| CRMD | CorMedix Inc | $660.09M | +5047.58% |
| IVA | Inventiva | $655.21M | +5009.57% |
| CTMX | CytomX Therapeutics Inc | $652.36M | +4987.34% |
| RLMD | Relmada Therapeutics Inc | $651.37M | +4979.57% |
| MDXG | Mimedx Group Inc | $635.94M | +4859.23% |
| RGNX | Regenxbio Inc | $633.34M | +4838.99% |
| PRME | Prime Medicine Inc | $630.35M | +4815.65% |
| NGNE | Neoleukin Therapeutics Inc | $616.04M | +4704.09% |
| TECX | AvroBio Inc | $611.99M | +4672.48% |
| FDMT | 4D Molecular Therapeutics Inc | $610.53M | +4661.13% |
| GYRE | Gyre Therapeutics Inc | $599.17M | +4572.53% |
| IMMX | Immix Biopharma Inc | $558.22M | +4253.15% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $555.56M | +4232.46% |
| CTNM | Contineum Therapeutics Inc - Class A | $546.27M | +4159.98% |
| ARVN | Arvinas Inc | $534.06M | +4064.77% |
| NVCT | Nuvectis Pharma Inc | $519.64M | +3952.28% |
| STTK | Shattuck Labs Inc | $511.69M | +3890.31% |
| ZURA | Zura Bio Ltd - Class A | $511.41M | +3888.11% |
| VSTM | Verastem Inc | $503.34M | +3825.21% |
| SLN | Silence Therapeutics Plc | $493.60M | +3749.26% |
| OCGN | Ocugen Inc | $483.80M | +3672.79% |
| KYTX | Kyverna Therapeutics Inc | $470.94M | +3572.56% |
| ALLO | Allogene Therapeutics Inc | $465.15M | +3527.39% |
| SVA | Sinovac Biotech Ltd | $464.94M | +3525.74% |
| CABA | Cabaletta Bio Inc | $463.15M | +3511.79% |
| RZLT | Rezolute Inc | $456.43M | +3459.35% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +3420.24% |
| EVMN | Evommune Inc | $447.71M | +3391.37% |
| PRTA | Prothena Corporation plc | $447.44M | +3389.28% |
| BNTC | Benitec Biopharma Inc | $447.29M | +3388.13% |
| VALN | Valneva SE | $440.98M | +3338.89% |
| CBIO | N/A | $432.05M | +3269.28% |
| STRO | Sutro Biopharma Inc | $430.74M | +3259.02% |
| AURA | Aura Biosciences Inc | $430.49M | +3257.09% |
| PBYI | Puma Biotechnology Inc | $427.89M | +3236.85% |
| ASMB | Assembly Biosciences Inc | $424.80M | +3212.74% |
| OVID | Ovid Therapeutics Inc | $416.49M | +3147.95% |
| ABEO | Abeona Therapeutics Inc | $414.56M | +3132.84% |
| DMAC | DiaMedica Therapeutics Inc | $411.67M | +3110.32% |
| CYBN | Cybin Inc | $408.43M | +3085.08% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +3048.67% |
| AUTL | Autolus Therapeutics plc | $401.88M | +3033.96% |
| RCKT | Rocket Pharmaceuticals Inc | $398.30M | +3006.08% |
| LRMR | Larimar Therapeutics Inc | $395.79M | +2986.52% |
| UPB | Upstream Bio Inc | $395.63M | +2985.27% |
| CCCC | C4 Therapeutics Inc | $395.34M | +2982.97% |
| IPSC | Century Therapeutics Inc | $390.82M | +2947.75% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +2942.81% |
| AVIR | Atea Pharmaceuticals Inc | $388.93M | +2933.01% |
| CMPX | Compass Therapeutics Inc | $385.39M | +2905.38% |
| ENTA | Enanta Pharmaceuticals Inc | $384.48M | +2898.27% |
| RVNC | Revance Therapeutics Inc | $380.38M | +2866.30% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +2839.84% |
| ALT | Altimmune Inc | $373.67M | +2814.03% |
| TENX | Tenax Therapeutics Inc | $372.39M | +2803.98% |
| PRLD | Prelude Therapeutics Inc | $368.04M | +2770.08% |
| XFOR | X4 Pharmaceuticals Inc | $367.85M | +2768.58% |
| FENC | Fennec Pharmaceuticals Inc | $366.13M | +2755.23% |
| VNDA | Vanda Pharmaceuticals Inc | $351.79M | +2643.37% |
| LXEO | Lexeo Therapeutics Inc | $351.17M | +2638.54% |
| EDIT | Editas Medicine Inc | $349.39M | +2624.61% |
| FATE | Fate Therapeutics Inc | $347.65M | +2611.12% |
| FBRX | Forte Biosciences Inc | $340.15M | +2552.61% |
| ZNTL | Zentalis Pharmaceuticals Inc | $340.13M | +2552.41% |
| PALI | Palisade Bio Inc | $339.87M | +2550.38% |
| IMAB | I-Mab | $339.64M | +2548.59% |
| EPRX | Eupraxia Pharmaceuticals Inc | $338.64M | +2540.85% |
| IMRX | Immuneering Corp Class A | $333.64M | +2501.82% |
| LYEL | Lyell Immunopharma Inc | $332.66M | +2494.21% |
| FHTX | Foghorn Therapeutics Inc | $319.97M | +2395.24% |
| INDP | Indaptus Therapeutics Inc | $319.34M | +2390.34% |
| ANL | Adlai Nortye Ltd | $317.46M | +2375.62% |
| GALT | Galectin Therapeutics Inc | $313.48M | +2344.61% |
| LCTX | Lineage Cell Therapeutics Inc | $305.39M | +2281.53% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +2278.95% |
| ELDN | Eledon Pharmaceuticals Inc | $304.92M | +2277.89% |
| SCPH | scPharmaceuticals Inc | $304.59M | +2275.29% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +2261.81% |
| OABI | OmniAb Inc | $301.15M | +2248.46% |
| BCYC | Bicycle Therapeutics Plc | $294.16M | +2193.98% |
| NMRA | Neumora Therapeutics Inc | $293.19M | +2186.40% |
| GLSI | Greenwich LifeSciences Inc | $286.57M | +2134.79% |
| TTRX | Turn Therapeutics Inc | $285.37M | +2125.40% |
| CLLS | Cellectis | $282.48M | +2102.88% |
| TRDA | Entrada Therapeutics Inc | $276.01M | +2052.45% |
| NAGE | Niagen Bioscience Inc | $275.72M | +2050.12% |
| MGNX | Macrogenics Inc | $274.58M | +2041.26% |
| SABS | SAB Biotherapeutics Inc | $274.20M | +2038.26% |
| ALXO | Alx Oncology Holdings Inc | $273.12M | +2029.86% |
| IKT | Inhibikase Therapeutics Inc | $271.99M | +2021.04% |
| SRZN | Surrozen Inc | $250.37M | +1852.44% |
| IRD | Ocuphire Pharma Inc | $248.48M | +1837.73% |
| RNAC | Cartesian Therapeutics Inc | $247.77M | +1832.17% |
| THRD | Third Harmonic Bio Inc | $241.86M | +1786.14% |
| FULC | Fulcrum Therapeutics Inc | $237.12M | +1749.17% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +1717.10% |
| ACIU | AC Immune SA | $232.87M | +1715.99% |
| AVXL | Anavex Life Sciences Corporation | $231.68M | +1706.71% |
| IVVD | Invivyd Inc | $231.05M | +1701.81% |
| QTTB | Q32 Bio Inc | $229.68M | +1691.14% |
| SLRN | Acelyrin Inc | $228.54M | +1682.26% |
| DTIL | Precision Biosciences Inc | $227.35M | +1672.95% |
| TARA | Protara Therapeutics Inc | $226.83M | +1668.88% |
| CGEN | Compugen Ltd | $223.15M | +1640.16% |
| CHRS | Coherus Biosciences Inc | $222.07M | +1631.80% |
| NAUT | Nautilus Biotechnology Inc | $221.10M | +1624.23% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +1604.77% |
| KROS | Keros Therapeutics Inc | $217.65M | +1597.33% |
| ADAG | Adagene Inc | $217.38M | +1595.21% |
| SLGL | Sol-Gel Technologies Ltd | $215.10M | +1577.45% |
| KPTI | Karyopharm Therapeutics Inc | $214.84M | +1575.42% |
| OBIO | Orchestra BioMed Holdings Inc | $214.00M | +1568.86% |
| RNA | Atrium Therapeutics Inc | $210.40M | +1540.76% |
| IMUX | Immunic Inc | $205.68M | +1503.99% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +1473.75% |
| CDXS | Codexis Inc | $200.88M | +1466.49% |
| NKTX | Nkarta Inc | $197.53M | +1440.37% |
| AGEN | Agenus Inc | $192.99M | +1405.03% |
| VYGR | Voyager Therapeutics Inc | $192.99M | +1405.02% |
| NERV | Minerva Neurosciences Inc | $189.40M | +1376.98% |
| KRRO | Korro Bio Inc | $187.93M | +1365.51% |
| PRQR | ProQR Therapeutics N.V | $186.49M | +1354.32% |
| PLX | Protalix BioTherapeutics Inc | $186.05M | +1350.86% |
| TNYA | Tenaya Therapeutics Inc | $182.97M | +1326.88% |
| MDWD | MediWound Ltd | $182.55M | +1323.61% |
| IFRX | InflaRx N.V. | $182.18M | +1320.68% |
| WHWK | Whitehawk Therapeutics Inc | $181.71M | +1317.01% |
| ARCT | Arcturus Therapeutics Holdings Inc | $181.62M | +1316.35% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +1310.02% |
| ACOG | Alpha Cognition Inc | $180.73M | +1309.35% |
| MENS | Jyong Biotech Ltd | $174.10M | +1257.72% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +1253.34% |
| PEPG | PepGen Inc | $168.86M | +1216.81% |
| ANTX | AN2 Therapeutics Inc | $168.05M | +1210.53% |
| CRBU | Caribou Biosciences Inc | $167.73M | +1207.98% |
| THTX | Theratechnologies Inc | $167.34M | +1204.94% |
| ALEC | Alector Inc | $166.54M | +1198.71% |
| ORMP | Oramed Pharmaceuticals Inc | $166.16M | +1195.77% |
| EQ | Equillium Inc | $165.65M | +1191.82% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $164.92M | +1186.13% |
| IPHA | Innate Pharma | $164.54M | +1183.15% |
| OTLK | Outlook Therapeutics Inc | $163.20M | +1172.67% |
| YDES | YD Bio Ltd | $160.69M | +1153.12% |
| ABOS | Acumen Pharmaceuticals Inc | $160.35M | +1150.42% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $159.83M | +1146.38% |
| LENZ | LENZ Therapeutics Inc | $156.46M | +1120.11% |
| PYXS | Pyxis Oncology Inc | $152.68M | +1090.65% |
| CNTB | Connect Biopharma Holdings Ltd | $152.39M | +1088.38% |
| HUMA | Humacyte Inc | $151.33M | +1080.10% |
| MIST | Milestone Pharmaceuticals Inc | $149.60M | +1066.62% |
| NBP | NovaBridge Biosciences. | $149.30M | +1064.27% |
| NRXP | NRX Pharmaceuticals Inc | $149.28M | +1064.15% |
| AKTX | Akari Therapeutics Plc | $148.12M | +1055.12% |
| MOLN | Molecular Partners AG | $146.63M | +1043.51% |
| ARMP | Armata Pharmaceuticals Inc | $146.49M | +1042.35% |
| AARD | Aardvark Therapeutics Inc | $145.52M | +1034.77% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +1033.53% |
| HURA | TuHURA Biosciences Inc | $144.96M | +1030.44% |
| GUTS | Fractyl Health Inc | $144.37M | +1025.85% |
| PROK | ProKidney Corp - Class A | $137.85M | +975.00% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +973.25% |
| CBUS | Cibus Global Ltd. Class A | $135.62M | +957.61% |
| THAR | Tharimmune Inc | $135.41M | +955.96% |
| SEER | Seer Inc - Class A | $132.16M | +930.64% |
| GNLX | Genelux Corp | $130.49M | +917.57% |
| VXRT | Vaxart Inc | $127.95M | +897.79% |
| ENGN | enGene Holdings Inc | $127.28M | +892.57% |
| UNCY | Unicycive Therapeutics Inc | $126.69M | +888.00% |
| PMN | ProMIS Neurosciences Inc | $125.59M | +879.41% |
| FBIO | Fortress Biotech Inc | $123.12M | +860.15% |
| RANI | Rani Therapeutics Holdings Inc Class A | $121.86M | +850.28% |
| VANI | Vivani Medical Inc | $119.35M | +830.76% |
| ANIX | Anixa Biosciences Inc | $118.73M | +825.89% |
| ALDX | Aldeyra Therapeutics Inc | $115.82M | +803.17% |
| SAVA | Cassava Sciences Inc. | $114.97M | +796.59% |
| RPTX | Repare Therapeutics Inc | $113.91M | +788.32% |
| COYA | Coya Therapeutics Inc | $113.53M | +785.36% |
| KLRS | Kalaris Therapeutics Inc | $110.82M | +764.23% |
| ONCY | Oncolytics Biotech Inc | $104.98M | +718.67% |
| HLVX | HilleVax Inc | $104.74M | +716.79% |
| BDTX | Black Diamond Therapeutics Inc | $103.72M | +708.81% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +698.57% |
| SPRO | Spero Therapeutics Inc | $98.42M | +667.48% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +662.21% |
| VRCA | Verrica Pharmaceuticals Inc | $97.23M | +658.24% |
| ICCC | Immucell Corp | $97.07M | +657.00% |
| PYPD | Polypid Ltd | $94.84M | +639.61% |
| BMEA | Biomea Fusion Inc | $93.27M | +627.32% |
| CUE | Cue Biopharma Inc | $92.75M | +623.26% |
| ENLV | Enlivex Ltd | $92.47M | +621.08% |
| PTHS | Channel Therapeutics Corporation | $91.66M | +614.81% |
| MAIA | MAIA Biotechnology Inc | $89.19M | +595.51% |
| NTHI | NeOnc Technologies Holdings Inc | $87.88M | +585.33% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +578.38% |
| CRDF | Cardiff Oncology Inc | $85.46M | +566.46% |
| RLYB | Rallybio Corp | $85.33M | +565.44% |
| CGTX | Cognition Therapeutics Inc | $84.81M | +561.34% |
| LPTX | Leap Therapeutics Inc | $84.76M | +560.98% |
| ATHE | Alterity Therapeutics Ltd | $84.66M | +560.21% |
| ACET | Adicet Bio Inc | $83.31M | +549.66% |
| HRTX | Heron Therapeutics Inc | $83.25M | +549.25% |
| ENTX | Entera Bio Ltd | $82.99M | +547.16% |
| INO | Inovio Pharmaceuticals Inc | $81.63M | +536.61% |
| CSBR | Champions Oncology Inc | $80.27M | +525.94% |
| NRXS | Neuraxis Inc | $79.92M | +523.25% |
| FBIOP | Fortress Biotech Inc | $77.72M | +506.09% |
| ATHA | Athira Pharma Inc | $77.21M | +502.14% |
| PMVP | PMV Pharmaceuticals Inc | $74.66M | +482.26% |
| GLTO | Galecto Inc | $74.66M | +482.19% |
| ACRV | Acrivon Therapeutics Inc | $74.39M | +480.12% |
| ATRA | Atara Biotherapeutics Inc | $72.78M | +467.54% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +460.90% |
| GANX | Gain Therapeutics Inc | $71.38M | +456.65% |
| XBIT | XBiotech Inc | $69.82M | +444.45% |
| PLRX | Pliant Therapeutics Inc | $69.34M | +440.77% |
| HYFT | MindWalk Holdings Corp | $69.31M | +440.49% |
| MNOV | Medicinova Inc | $68.91M | +437.38% |
| SPRB | Spruce Biosciences Inc | $67.96M | +429.94% |
| IMA | Ikena Oncology Inc | $67.49M | +426.32% |
| ELTX | Elicio Therapeutics Inc | $65.05M | +407.31% |
| IMMP | Immutep Ltd | $64.23M | +400.89% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +395.61% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +393.01% |
| EDSA | Edesa Biotech Inc | $61.04M | +376.05% |
| OSTX | OS Therapies Inc | $60.88M | +374.77% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +361.66% |
| IBIO | iBio Inc | $58.38M | +355.25% |
| CNTX | Context Therapeutics Inc | $57.91M | +351.61% |
| OKYO | OKYO Pharma Ltd - New | $56.13M | +337.73% |
| BOLD | Boundless Bio Inc | $55.35M | +331.60% |
| INMB | INmune Bio Inc | $55.03M | +329.15% |
| CING | Cingulate Inc | $54.66M | +326.25% |
| KZR | Kezar Life Sciences Inc | $53.76M | +319.23% |
| INKT | MiNK Therapeutics Inc | $53.21M | +314.93% |
| XLO | Xilio Therapeutics Inc | $52.74M | +311.26% |
| MREO | Mereo Biopharma Group Plc | $52.58M | +310.05% |
| ATYR | Atyr Pharma Inc | $52.39M | +308.54% |
| MCRB | Seres Therapeutics Inc | $52.28M | +307.68% |
| BYSI | BeyondSpring Inc | $52.22M | +307.24% |
| EXOZ | Invizyne Technologies Inc | $51.89M | +304.67% |
| RNTX | Rein Therapeutics Inc | $51.79M | +303.91% |
| TIL | Instil Bio Inc | $51.68M | +303.01% |
| ANVS | Annovis Bio Inc | $51.65M | +302.80% |
| GOSS | Gossamer Bio Inc | $51.14M | +298.81% |
| IBO | Impact BioMedical Inc | $50.13M | +290.90% |
| MGX | Metagenomi Inc | $48.56M | +278.72% |
| DWTX | Virios Therapeutics Inc | $48.10M | +275.09% |
| LVTX | LAVA Therapeutics NV | $45.77M | +256.94% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +256.59% |
| DYAI | Dyadic International Inc DE | $44.46M | +246.68% |
| PDSB | PDS Biotechnology Corporation | $41.64M | +224.71% |
| APLM | Apollomics Inc - Class A | $41.33M | +222.32% |
| ACTU | Actuate Therapeutics Inc | $40.78M | +218.05% |
| FGEN | FibroGen Inc | $39.31M | +206.52% |
| GRCE | Acasti Pharma Inc | $38.94M | +203.65% |
| VERU | Veru Inc | $38.84M | +202.90% |
| RNXT | RenovoRx Inc | $38.73M | +202.01% |
| NNVC | NanoViricides Inc | $37.23M | +190.35% |
| NTRB | Nutriband Inc | $37.08M | +189.13% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +181.56% |
| GBIO | Generation Bio Company | $35.97M | +180.49% |
| GNTA | Genenta Science SpA | $35.85M | +179.58% |
| ALGS | Aligos Therapeutics Inc | $35.71M | +178.45% |
| MURA | Mural Oncology plc | $35.34M | +175.61% |
| LTRN | Lantern Pharma Inc | $34.89M | +172.08% |
| LITS | Lite Strategy Inc | $34.77M | +171.17% |
| HYPD | Eyenovia Inc | $34.51M | +169.15% |
| LSTA | Lisata Therapeutics Inc | $34.15M | +166.33% |
| ABVC | ABVC BioPharma Inc | $32.98M | +157.21% |
| ESLA | Estrella Immunopharma Inc | $32.50M | +153.48% |
| SNTI | Senti Biosciences Inc | $32.39M | +152.59% |
| DARE | Dare Bioscience Inc | $30.14M | +135.03% |
| SER | AgeX Therapeutics Inc | $29.05M | +126.56% |
| SGMO | Sangamo Therapeutics Inc | $28.83M | +124.84% |
| BCTX | BriaCell Therapeutics Corp - New | $28.57M | +122.77% |
| ATNM | Actinium Pharmaceuticals Inc | $28.56M | +122.72% |
| CRVO | CervoMed Inc | $28.42M | +121.66% |
| PSTV | Plus Therapeutics Inc | $28.00M | +118.33% |
| TVRD | Cara Therapeutics Inc | $27.49M | +114.35% |
| BRNS | Barinthus Biotherapeutics Plc. | $26.44M | +106.17% |
| IGC | IGC Pharma Inc | $26.36M | +105.55% |
| EVAX | Evaxion Biotech A/S | $25.44M | +98.37% |
| VYNE | VYNE Therapeutics Inc | $25.25M | +96.94% |
| GRDX | Entero Therapeutics Inc | $24.74M | +92.92% |
| NXTC | Nextcure Inc | $23.92M | +86.52% |
| MRKR | Marker Therapeutics Inc | $23.55M | +83.63% |
| NRSN | NeuroSense Therapeutics Ltd | $23.41M | +82.52% |
| CELU | Celularity Inc - Class A | $22.49M | +75.41% |
| OPT | Opthea Ltd | $21.53M | +67.89% |
| SKYE | Skye Bioscience Inc | $21.29M | +66.03% |
| PLRZ | Polyrizon Ltd | $21.02M | +63.92% |
| ATOS | Atossa Therapeutics Inc | $21.01M | +63.86% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +58.90% |
| TVGN | Tevogen Bio Holdings Inc | $19.93M | +55.39% |
| SNSE | Sensei Biotherapeutics Inc | $19.48M | +51.87% |
| JSPR | Jasper Therapeutics Inc | $19.37M | +51.08% |
| KALA | Kala Bio Inc | $19.15M | +49.32% |
| NEUP | Neuphoria Therapeutics Inc | $18.93M | +47.61% |
| NCEL | NLS Pharmaceutics Ltd | $18.85M | +47.03% |
| ALLR | Allarity Therapeutics Inc | $18.67M | +45.57% |
| ICU | SeaStar Medical Holding Corp | $18.45M | +43.89% |
| PLUR | Pluri Inc | $18.25M | +42.35% |
| LPCN | Lipocine Inc | $17.64M | +37.57% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $17.55M | +36.89% |
| HOWL | Werewolf Therapeutics Inc | $16.50M | +28.66% |
| HIND | ReShape Lifesciences Inc | $15.93M | +24.24% |
| PTN | Palatin Technologies Inc | $15.81M | +23.28% |
| PASG | Passage Bio Inc | $15.75M | +22.83% |
| LGVN | Longeveron Inc - Class A | $15.75M | +22.80% |
| CYCN | Cyclerion Therapeutics Inc | $15.74M | +22.71% |
| TPST | Tempest Therapeutics Inc | $15.35M | +19.69% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +16.72% |
| APLT | Applied Therapeutics Inc | $14.86M | +15.91% |
| HOTH | Hoth Therapeutics Inc | $14.64M | +14.19% |
| LEXX | Lexaria Bioscience Corp | $14.58M | +13.68% |
| IOBT | IO Biotech Inc | $14.50M | +13.06% |
| HOOK | Hookipa Pharma Inc | $14.43M | +12.50% |
| INAB | IN8bio Inc | $14.18M | +10.58% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $14.00M | +9.17% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $13.82M | +7.78% |
| BIVI | BioVie Inc - Class A | $13.35M | +4.10% |
| BLRX | Bioline Rx Ltd | $13.35M | +4.07% |
| LNAI | Lunai Bioworks Inc | $13.33M | +3.92% |
| QNCX | Quince Therapeutics Inc | $13.03M | +1.64% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +1.54% |
| GTBP | GT Biopharma Inc | $12.33M | -3.86% |
| MBRX | Moleculin Biotech Inc | $12.33M | -3.87% |
| CALC | CalciMedica Inc | $12.31M | -4.04% |
| INTS | Intensity Therapeutics Inc | $12.30M | -4.11% |
| AIM | AIM ImmunoTech Inc. | $12.01M | -6.34% |
| KTTA | Pasithea Therapeutics Corp | $11.92M | -7.03% |
| QNRX | Quoin Pharmaceuticals Ltd | $11.92M | -7.06% |
| CTXR | Citius Pharmaceuticals Inc | $11.88M | -7.32% |
| GDTC | CytoMed Therapeutics Ltd | $11.32M | -11.72% |
| TOVX | Theriva Biologics Inc | $11.15M | -13.07% |
| CMMB | Chemomab Therapeutics Ltd | $10.93M | -14.75% |
| BCLI | Brainstorm Cell Therapeutics Inc | $10.73M | -16.30% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -18.69% |
| PHIO | Phio Pharmaceuticals Corp | $10.34M | -19.36% |
| XCUR | Exicure Inc | $10.33M | -19.48% |
| CVM | Cel-Sci Corp | $10.15M | -20.88% |
| MLEC | Moolec Science SA | $10.06M | -21.57% |
| KPRX | Kiora Pharmaceuticals Inc | $9.90M | -22.77% |
| BCDA | BioCardia Inc | $9.59M | -25.25% |
| MTVA | MetaVia Inc | $9.55M | -25.49% |
| VTGN | VistaGen Therapeutics Inc | $9.48M | -26.10% |
| CRIS | Curis Inc | $9.45M | -26.27% |
| TRAW | Traws Pharma Inc | $9.16M | -28.56% |
| ASBP | Aspire Biopharma Holdings Inc | $9.03M | -29.58% |
| EPIX | Essa Pharma Inc | $8.93M | -30.35% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -30.46% |
| IMNN | Imunon Inc | $8.71M | -32.10% |
| BRTX | BioRestorative Therapies Inc | $8.66M | -32.45% |
| APRE | Aprea Therapeutics Inc | $8.48M | -33.88% |
| ADXN | Addex Therapeutics Ltd | $8.21M | -36.01% |
| SYBX | Synlogic Inc | $8.20M | -36.03% |
| IMRN | Immuron Ltd | $8.15M | -36.43% |
| BOLT | Bolt Biotherapeutics Inc | $8.09M | -36.91% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -37.14% |
| RNAZ | TransCode Therapeutics Inc | $7.97M | -37.82% |
| ERNA | Ernexa Therapeutics Inc | $7.85M | -38.81% |
| PMCB | PharmaCyte Biotech Inc | $7.57M | -40.94% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $7.49M | -41.63% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -42.79% |
| AEON | AEON Biopharma Inc - Class A | $7.31M | -42.99% |
| BCAB | BioAtla Inc | $7.07M | -44.87% |
| CANF | Can-Fite Biopharma Ltd | $6.87M | -46.39% |
| KAPA | Kairos Pharma Ltd | $6.75M | -47.37% |
| XBIO | Xenetic Biosciences Inc | $6.65M | -48.13% |
| JUNS | Jupiter Neurosciences Inc | $6.48M | -49.50% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | -50.09% |
| GOVX | Geovax Labs Inc | $6.29M | -50.98% |
| CURX | Curanex Pharmaceuticals Inc | $6.11M | -52.38% |
| PPBT | Purple Biotech Ltd | $6.05M | -52.82% |
| HCWB | HCW Biologics Inc | $6.02M | -53.03% |
| APM | Aptorum Group Limited Class A Ordinary Shares | $6.01M | -53.11% |
| ACXP | Acurx Pharmaceuticals Inc | $5.93M | -53.75% |
| CVKD | Cadrenal Therapeutics Inc | $5.89M | -54.06% |
| PULM | Pulmatrix Inc | $5.73M | -55.28% |
| EVGN | Evogene Ltd | $5.64M | -55.99% |
| APVO | Aptevo Therapeutics Inc | $5.50M | -57.10% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.30M | -58.69% |
| SILO | SILO Pharma Inc | $5.29M | -58.75% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -59.22% |
| LIMN | Liminatus Pharma Inc | $5.14M | -59.93% |
| TCRT | Alaunos Therapeutics Inc | $5.07M | -60.49% |
| BGMS | Bio Green Med Solution Inc | $5.00M | -61.03% |
| NCNA | NuCana plc | $4.99M | -61.08% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -61.71% |
| CLGN | CollPlant Biotechnologies Ltd New | $4.80M | -62.60% |
| ALZN | Alzamend Neuro Inc | $4.68M | -63.51% |
| GNPX | Genprex Inc | $4.44M | -65.37% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -66.74% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -66.75% |
| REVB | Revelation Biosciences Inc | $4.26M | -66.78% |
| MBIO | Mustang Bio Inc | $4.25M | -66.83% |
| ADIL | Adial Pharmaceuticals Inc | $4.24M | -66.93% |
| ENVB | Enveric Biosciences Inc | $4.15M | -67.62% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -67.73% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $4.09M | -68.13% |
| SNGX | Soligenix Inc | $3.91M | -69.49% |
| PBM | Psyence Biomedical Ltd | $3.76M | -70.65% |
| CELZ | Creative Medical Technology Holdings Inc | $3.70M | -71.17% |
| GLMD | Galmed Pharmaceuticals Ltd | $3.38M | -73.65% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -73.94% |
| FBLG | FibroBiologics Inc | $3.18M | -75.20% |
| SLXN | Silexion Therapeutics Corp | $3.11M | -75.74% |
| SPRC | SciSparc Ltd | $3.05M | -76.25% |
| BDRX | Biodexa Pharmaceuticals Plc | $2.98M | -76.75% |
| AFMD | Affimed N.V. | $2.98M | -76.80% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -77.57% |
| ARTL | Artelo Biosciences Inc | $2.75M | -78.58% |
| GRI | GRI Bio Inc | $2.57M | -79.98% |
| ONCO | Onconetix Inc | $2.54M | -80.20% |
| PPCB | Propanc Biopharma Inc | $2.50M | -80.49% |
| VIVS | VivoSim Labs Inc | $2.47M | -80.75% |
| OGEN | Oragenics Inc | $2.45M | -80.89% |
| NBY | Stablecoin Development Corp | $2.40M | -81.25% |
| NTBL | Notable Labs Inc Ord | $2.39M | -81.33% |
| BBLG | Bone Biologics Corp | $2.23M | -82.64% |
| AZTR | Azitra Inc | $2.22M | -82.66% |
| MTNB | Matinas Biopharma Holdings Inc | $2.18M | -82.98% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -83.27% |
| CMND | Clearmind Medicine Inc | $2.12M | -83.51% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -83.72% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -84.45% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -87.84% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -88.15% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -88.87% |
| JAGX | Jaguar Health Inc | $1.34M | -89.52% |
| ZVSA | ZyVersa Therapeutics Inc | $1.03M | -91.97% |
| LYRA | Lyra Therapeutics Inc | $927198.36 | -92.77% |
| SCNI | Scinai Immunotherapeutics Ltd | $912143.15 | -92.89% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -95.70% |
| PTIX | Protagenic Therapeutics Inc | $503648.74 | -96.07% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -96.52% |
| ELAB | PMGC Holdings Inc | $221376.00 | -98.27% |
| CDT | CDT Equity Inc | $110551.31 | -99.14% |
| ADTX | Aditxt Inc | $98471.97 | -99.23% |